Information Provided By:
Fly News Breaks for July 15, 2019
Jul 15, 2019 | 04:47 EDT
Goldman Sachs analyst Patrick Donnelly downgraded Quest Diagnostics to Sell from Neutral and lowered his price target for the shares to $85 from $90. The analyst sees a "challenging" setup for the shares amid "muted" Preferred Lab Network prospects.
News For DGX From the Last 2 Days
There are no results for your query DGX